Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth
Juan Chen(Hunan University of Science and Technology), Ben C.B. Ko(Hong Kong Polytechnic University), Anthony W.I. Lo(Chinese University of Hong Kong), Ailong Huang(Chongqing Medical University), Ka‐Fai To(Chinese University of Hong Kong), Ho‐Keung Ng(Chinese University of Hong Kong), Bin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Yu(Yueyang Second People's Hospital), Suk-Hang Cheng(Chinese University of Hong Kong), Anthony W.H. Chan(Chinese University of Hong Kong), Nathalie Wong(Chinese University of Hong Kong), Margaret H.L. Ng, Xue-Fei Cai(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), Ming‐Tat Ling(Chinese University of Hong Kong), Cecilia Y.S. Ho(Chinese University of Hong Kong)
Cited by 189
Related Papers
Antibody responses to SARS-CoV-2 in patients with COVID-19
|Nature Medicine|2020|3.1k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Pathophysiology of acute wound healing
|Clinics in Dermatology|2007|1.5k